Comment
The oral chelator deferasirox--a new perspective for patients with iron overload
Affiliations
- PMID: 16818263
Item in Clipboard
Comment
The oral chelator deferasirox--a new perspective for patients with iron overload
Haematologica.
2006 Jul.
No abstract available
Comment on
-
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.Haematologica. 2006 Jul;91(7):873-80. Haematologica. 2006. PMID: 16818273 Clinical Trial.
Similar articles
-
Current status of iron overload and chelation with deferasirox.Indian J Pediatr. 2007 Aug;74(8):759-64. doi: 10.1007/s12098-007-0134-7. Indian J Pediatr. 2007. PMID: 17785900 Review.
-
Deferasirox (Exjade): a new iron chelator.Med Lett Drugs Ther. 2006 Apr 24;48(1233):35-6. Med Lett Drugs Ther. 2006. PMID: 16625144 Review. No abstract available.
-
Deferasirox--an oral agent for chronic iron overload.Ann Pharmacother. 2006 Jun;40(6):1110-7. doi: 10.1345/aph.1G566. Epub 2006 May 30. Ann Pharmacother. 2006. PMID: 16735647 Review.
-
Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload.Expert Opin Pharmacother. 2008 Sep;9(13):2391-402. doi: 10.1517/14656566.9.13.2391. Expert Opin Pharmacother. 2008. PMID: 18710363 Review.
-
Deferasirox and children: From clinical trials to the real world.Am J Hematol. 2016 Jun;91(6):E304-5. doi: 10.1002/ajh.24353. Epub 2016 Apr 13. Am J Hematol. 2016. PMID: 26950047 No abstract available.
Cited by
-
Current status of iron overload and chelation with deferasirox.Indian J Pediatr. 2007 Aug;74(8):759-64. doi: 10.1007/s12098-007-0134-7. Indian J Pediatr. 2007. PMID: 17785900 Review.